The Institute for Policy Innovation held a briefing on October 14, 2011, featuring testimonies from health care and FDA experts examining how and why the CDC may be restricting access to a new meningitis vaccine for infants. The briefing also featured the release of a new study evaluating the disparities in how government programs place economic value on human life.